• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Afatinib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5756697

Afatinib is an irreversible inhibitor of EGFR family (EGFR-wt, EGFR-L858R, EGFR-L858R/T790M and HER2 with IC50s of 0.5nM, 0.4nM, 10nM and 14nM, respectively). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Afatinib, Inhibitor
Full Product Name
Afatinib free base
Product Synonym Names
BIBW 2992
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
485.94
Solubility
DMSO: 95mg/mL (195.4mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C24H25ClFN5O3
SMILES
CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4
CAS Number
850140-72-6
Target & IC50
EGFR: ic50 0.5nM
HER2: ic50 14nM
EGFRL858R: ic50 0.4nM
EGFRL858R/T790M: ic50 10nM
In Vitro
Afatinib could effectively inhibit HKESC-2 tumor growth in mice without obvious toxicity[1].

Structure of Afatinib, inhibitor

Afatinib Inhibitor – Cat# MBS5756697

Product References and Citations for Afatinib, inhibitor

Wong CH, et al. Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC). Am J Cancer Res. 2015 Nov 15;5(12):3588-99.
Wong CH, et al. Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC). Am J Cancer Res. 2015 Nov 15;5(12):3588-99.
Wang XK, et al. Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo. Oncotarget. 2014 Dec 15;5(23):11971-85.
Wang XK, et al. Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo. Oncotarget. 2014 Dec 15;5(23):11971-85.

Other Notes

Small volumes of Afatinib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Afatinib purchase

MBS5756697 is an inhibitor targeting Afatinib. Also known as Afatinib free base.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000